EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents

Mesut Işık iD, Abdüllatif Karakaya iD, Ulviye Acar Çevik iD, Adem Necip iD, Hatice Esra Duran iD, Bilge Çiftçi iD, Yusuf Özkay iD, Zafer Asım Kaplancıklı iD, Şükrü Beydemir iD

Molecules · 29.07.2026 · 31 (15) · 2635

DOI: 10.3390/molecules31152635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 29.07.2026. Verfasst von Mesut Işık und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Faculty of Engineering, Bilecik Şeyh Edebali University, 11230 Bilecik, Turkey. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Benzimidazoles, Oxadiazoles, Hypoglycemic Agents. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anadolu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, due to the side effect profiles and low efficacy of currently used inhibitors, novel benzimidazole-oxadiazole derivatives (6a–6e, 7a–7e) were synthesized as dual inhibitors of α-GLY and AR. Their structures were elucidated using 13C-NMR and 1H-NMR techniques. Their binding properties were investigated by molecular docking studies, and their ADME properties were screened in silico. AR and α-GLY inhibitory effects of the synthesized compounds were examined. The compounds were observed to exhibit partially similar inhibitory effects to the reference drug epalrestate (IC50: 0.78 nM; KI: 0.74 ± 0.0 nM) on AR inhibition. Among them, compounds 6a, 6b, and 6c showed the highest activity with KI values of 8.6 ± 0.4, 3.5 ± 0.3 and 6.3 ± 0.5 nM, respectively. Compounds 6a and 7e were found to have higher inhibitory activity against the α-GLY enzyme than the reference drug Acarbose (IC50: 128.4 µM; KI: 96.2 ± 5.7 µM) with KI values of 5.8 ± 0.4 and 7.9 ± 0.8 µM, respectively. Overall, the newly synthesized compounds demonstrated pronounced AR inhibitory activity and notable α-GLY inhibition. Nevertheless, further pharmacological and toxicity evaluations are required to confirm their therapeutic potential. Among the tested molecules, compounds 6a and 7e may therefore be considered potential candidates for further investigation as anti-diabetic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationBenzimidazolesOxadiazolesHypoglycemic Agentsalpha-GlucosidasesGlycoside Hydrolase InhibitorsDrug DesignAldehyde ReductaseStructure-Activity RelationshipMolecular StructureHumans

Stichwörter der Autor:innen

aldose reductasebenzimidazolemolecular dockingoxadiazoleα-glucosidase

Substanzen

BenzimidazolesOxadiazolesHypoglycemic Agentsalpha-GlucosidasesGlycoside Hydrolase InhibitorsAldehyde Reductasebenzimidazole

Autor:innen und Institutionen

  • Department of Bioengineering, Faculty of Engineering, Bilecik Şeyh Edebali University, 11230 Bilecik, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Zonguldak Bulent Ecevit University, 67600 Zonguldak, Turkey.
  • Department of Pharmaceutical Chemistry, Graduate School, Anadolu University, 26470 Eskisehir, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskisehir, Turkey.
  • Department of Pharmacy Services, Vocational School of Health Services, Harran University, 63300 Şanlıurfa, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Kafkas University, 36100 Kars, Turkey.

ORCID-Profile: Mesut Işık, Abdüllatif Karakaya, Ulviye Acar Çevik, Adem Necip, Hatice Esra Duran, Bilge Çiftçi, Yusuf Özkay, Zafer Asım Kaplancıklı, Şükrü Beydemir

Förderung

  • Anadolu University

Zitieren

APA

Işık, M., Karakaya, A., Çevik, U. A., Necip, A., Duran, H. E., Çiftçi, B., Özkay, Y., Kaplancıklı, Z. A., & Beydemir, Ş. (2026). Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents. Molecules, 31(15), 2635. https://doi.org/10.3390/molecules31152635

Vancouver

Işık M, Karakaya A, Çevik UA, Necip A, Duran HE, Çiftçi B, et al. Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents. Molecules. 2026;31(15):2635. doi:10.3390/molecules31152635

BibTeX
@article{Ik2026,
  author = {Işık, Mesut and Karakaya, Abdüllatif and Çevik, Ulviye Acar and Necip, Adem and Duran, Hatice Esra and Çiftçi, Bilge and Özkay, Yusuf and Kaplancıklı, Zafer Asım and Beydemir, Şükrü},
  title = {Design, Synthesis, In Silico ADME, Toxicity Prediction and Molecular Docking Studies of Benzimidazole-Oxadiazole Derivatives for α-Glucosidase and Aldose Reductase Pathways as Potent Anti-Diabetic Agents},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {15},
  pages = {2635},
  doi = {10.3390/molecules31152635}
}
Kostenlos starten →